IGF-BP2 Recombinant Protein

• Background:

  IGF-BPs controls the distribution, function and activity of IGFs in various cell tissues and body fluids. Currently there are seven named IGF-BPs that form high affinity complexes with both IGF-I and IGF-II. IGF-BP2 is a cysteine-rich secreted protein produced by bone cells, and is most abundant in the brain. IGF-BP2 has been shown to inhibit IGF-II action in human breast and ovarian carcinoma cells. Recombinant human IGF-BP2 is a 31.5 kDa protein consisting of 289 amino acid residues including the IGF-BP domain and thyroglobulin type-I domain.

• NCBI Gene ID:

  3485

• Swiss Prot:

  P18065

• Accession Number:

  NP_000588.2

• Type:

  Recombinant Proteins

• Field of Research:

  Cancer, Signal Transduction

• Shipping Conditions:

  Room Temp

• Storage Conditions:

  The lyophilized IGF-BP2 recombinant protein is stable for at least 2 years from date of receipt at -20˚ C. Reconstituted IGF-BP2 is stable for at least 3 months when stored in working aliquots with a carrier protein at -20˚ C. As with any protein, exposing IGF-BP2 recombinant protein to repeated freeze / thaw cycles is not recommended. When working with proteins care should be taken to keep recombinant protein at a cool and stable temperature.

• NCBI Official Name:

  Insulin-like growth factor binding protein 2, 36kDa

• NCBI Organism:

  Homo sapiens

• Other Product Names:

  IBP2, IGF-BP53, BP2, IBP2, Insulin-like growth factor-binding protein 2, IBP-2

• Species:

  Human

• Protein ID:

  55925576

• Physical Properties:

  Lyophilized